[1] HILCHIE A L, WUERTH K, HANCOCK R E. Immune modulation by multifaceted cationic host defense (antimicrobial) peptides [J]. Nat Chem Biol, 2013, 9(12): 761 − 768. doi:  10.1038/nchembio.1393
[2] 刘敬, 李薇, 孙国文. 人源抗菌肽LL-37对柯萨奇B3病毒诱导的病毒性心肌炎小鼠病毒复制及炎症反应的影响[J]. 岭南心血管病杂志, 2022, 28(4): 349 − 354. doi:  10.3969/j.issn.1007-9688.2022.04.13
[3] 齐志涛, 徐杨, 邹钧, 等. 水产动物抗菌肽研究进展[J]. 水产学报, 2020, 44(9): 1572 − 1583.
[4] LAI S, ZHANG Q, JIN L. Natural and Man-Made Cyclic Peptide-Based Antibiotics [J]. Antibiotics (Basel), 2022, 12(1): 1 − 11. doi:  10.3390/antibiotics12010001
[5] 孙明杰, 盛永杰, 郝木强, 等. 天蚕素抗菌肽在饲料应用中的安全性研究[J]. 中国饲料, 2022(3): 43 − 46.
[6] 彭会, 王克坚. 海洋鱼类和甲壳类抗菌肽的研究进展与应用前景[J]. 渔业研究, 2016, 38(3): 254 − 262.
[7] BORMANN N, KOLISZAK A, KASPER S, et al. A short artificial antimicrobial peptide shows potential to prevent or treat bone infections [J]. Sci Rep, 2017, 7(1): 1506. doi:  10.1038/s41598-017-01698-0
[8] XIAO Y, CAI Y, BOMMINENI Y R, et al. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity [J]. Journal of Biological Chemistry, 2006, 281(5): 2858 − 2867. doi:  10.1074/jbc.M507180200
[9] XIAO Y, DAI H, BOMMINENI Y R, et al. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken [J]. The FEBS Journal, 2006, 273(12): 2581 − 2593. doi:  10.1111/j.1742-4658.2006.05261.x
[10] RAJASEKARAN G, KUMAR S D, YANG S, et al. The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities [J]. Eur J Med Chem, 2019, 182: 111623. doi:  10.1016/j.ejmech.2019.111623
[11] HANCOCK R, ALFORD M A, HANEY E F. Antibiofilm activity of host defence peptides: complexity provides opportunities [J]. Nat Rev Microbiol, 2021, 19(12): 786 − 797. doi:  10.1038/s41579-021-00585-w
[12] JOO H S, FU C I, OTTO M. Bacterial strategies of resistance to antimicrobial peptides [J]. Philos Trans R Soc Lond B Biol Sci, 2016, 371(1695): .1 − 11. doi:  10.1098/rstb.2015.0292
[13] MOOKHERJEE N, ANDERSON M A, HAAGSMAN H P, et al. Antimicrobial host defence peptides: functions and clinical potential [J]. Nat Rev Drug Discov, 2020, 19(5): 311 − 332. doi:  10.1038/s41573-019-0058-8
[14] NGUYEN L T, HANEY E F, VOGEL H J. The expanding scope of antimicrobial peptide structures and their modes of action [J]. Trends Biotechnol, 2011, 29(9): 464 − 472. doi:  10.1016/j.tibtech.2011.05.001
[15] ROOPE L, SMITH R D, POUWELS K B, et al. The challenge of antimicrobial resistance: What economics can contribute [J]. Science, 2019, 364(6435): 4679. doi:  10.1126/science.aau4679